
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS
Paul J. Hop, Ramona A.J. Zwamborn, Eilís Hannon, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 633
Open Access | Times Cited: 66
Paul J. Hop, Ramona A.J. Zwamborn, Eilís Hannon, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 633
Open Access | Times Cited: 66
Showing 1-25 of 66 citing articles:
Amyotrophic lateral sclerosis: translating genetic discoveries into therapies
Fulya Akçimen, Elia R. Lopez, John E. Landers, et al.
Nature Reviews Genetics (2023) Vol. 24, Iss. 9, pp. 642-658
Open Access | Times Cited: 112
Fulya Akçimen, Elia R. Lopez, John E. Landers, et al.
Nature Reviews Genetics (2023) Vol. 24, Iss. 9, pp. 642-658
Open Access | Times Cited: 112
Current State and Future Directions in the Therapy of ALS
Laura Tzeplaeff, Sibylle Wilfling, Maria Viktoria Requardt, et al.
Cells (2023) Vol. 12, Iss. 11, pp. 1523-1523
Open Access | Times Cited: 56
Laura Tzeplaeff, Sibylle Wilfling, Maria Viktoria Requardt, et al.
Cells (2023) Vol. 12, Iss. 11, pp. 1523-1523
Open Access | Times Cited: 56
Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery
Satoru Morimoto, Shinichi Takahashi, Daisuke Ito, et al.
Cell stem cell (2023) Vol. 30, Iss. 6, pp. 766-780.e9
Open Access | Times Cited: 42
Satoru Morimoto, Shinichi Takahashi, Daisuke Ito, et al.
Cell stem cell (2023) Vol. 30, Iss. 6, pp. 766-780.e9
Open Access | Times Cited: 42
Innate immune activation in neurodegenerative diseases
Sergio Castro‐Gomez, Michael T. Heneka
Immunity (2024) Vol. 57, Iss. 4, pp. 790-814
Closed Access | Times Cited: 21
Sergio Castro‐Gomez, Michael T. Heneka
Immunity (2024) Vol. 57, Iss. 4, pp. 790-814
Closed Access | Times Cited: 21
The amyotrophic lateral sclerosis exposome: recent advances and future directions
Stephen A. Goutman, Masha G. Savelieff, Dae-Gyu Jang, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 10, pp. 617-634
Open Access | Times Cited: 40
Stephen A. Goutman, Masha G. Savelieff, Dae-Gyu Jang, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 10, pp. 617-634
Open Access | Times Cited: 40
Nutritional and metabolic factors in amyotrophic lateral sclerosis
Albert C. Ludolph, Luc Dupuis, Edward J. Kasarskis, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 9, pp. 511-524
Closed Access | Times Cited: 29
Albert C. Ludolph, Luc Dupuis, Edward J. Kasarskis, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 9, pp. 511-524
Closed Access | Times Cited: 29
L-Carnitine in the Treatment of Psychiatric and Neurological Manifestations: A Systematic Review
Wenbo Wang, Da Pan, Qi Liu, et al.
Nutrients (2024) Vol. 16, Iss. 8, pp. 1232-1232
Open Access | Times Cited: 11
Wenbo Wang, Da Pan, Qi Liu, et al.
Nutrients (2024) Vol. 16, Iss. 8, pp. 1232-1232
Open Access | Times Cited: 11
Advancing personalized medicine in neurodegenerative diseases: The role of epigenetics and pharmacoepigenomics in pharmacotherapy
Christian Griñán‐Ferré, Aina Bellver‐Sanchís, Ana Guerrero, et al.
Pharmacological Research (2024) Vol. 205, pp. 107247-107247
Open Access | Times Cited: 9
Christian Griñán‐Ferré, Aina Bellver‐Sanchís, Ana Guerrero, et al.
Pharmacological Research (2024) Vol. 205, pp. 107247-107247
Open Access | Times Cited: 9
Targeting common disease pathomechanisms to treat amyotrophic lateral sclerosis
Kiterie M. E. Faller, Helena Chaytow, Thomas H. Gillingwater
Nature Reviews Neurology (2025) Vol. 21, Iss. 2, pp. 86-102
Closed Access | Times Cited: 1
Kiterie M. E. Faller, Helena Chaytow, Thomas H. Gillingwater
Nature Reviews Neurology (2025) Vol. 21, Iss. 2, pp. 86-102
Closed Access | Times Cited: 1
Epigenetics in Neurodegenerative Diseases
Brigitte van Zundert, Martı́n Montecino
Sub-cellular biochemistry/Subcellular biochemistry (2025), pp. 73-109
Closed Access | Times Cited: 1
Brigitte van Zundert, Martı́n Montecino
Sub-cellular biochemistry/Subcellular biochemistry (2025), pp. 73-109
Closed Access | Times Cited: 1
Epigenetic regulation of TDP-43: potential implications for amyotrophic lateral sclerosis
D. Y. Mengistu, Monica Terribili, C. Pellacani, et al.
Frontiers in Molecular Medicine (2025) Vol. 5
Open Access | Times Cited: 1
D. Y. Mengistu, Monica Terribili, C. Pellacani, et al.
Frontiers in Molecular Medicine (2025) Vol. 5
Open Access | Times Cited: 1
Whole-genome bisulfite sequencing of cell-free DNA unveils age-dependent and ALS-associated methylation alterations
Yulin Jin, Karen N. Conneely, Wenjing Ma, et al.
Cell & Bioscience (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Yulin Jin, Karen N. Conneely, Wenjing Ma, et al.
Cell & Bioscience (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Recent advances in the genetics of familial and sporadic ALS
Ammar Al‐Chalabi, Jinsy Andrews, Sali M.K. Farhan
International review of neurobiology (2024), pp. 49-74
Closed Access | Times Cited: 6
Ammar Al‐Chalabi, Jinsy Andrews, Sali M.K. Farhan
International review of neurobiology (2024), pp. 49-74
Closed Access | Times Cited: 6
Lipids shape brain function through ion channel and receptor modulations: physiological mechanisms and clinical perspectives
Salvatore Incontro, Maria Laura Musella, Malika Sammari, et al.
Physiological Reviews (2024) Vol. 105, Iss. 1, pp. 137-207
Closed Access | Times Cited: 6
Salvatore Incontro, Maria Laura Musella, Malika Sammari, et al.
Physiological Reviews (2024) Vol. 105, Iss. 1, pp. 137-207
Closed Access | Times Cited: 6
Lipid Metabolic Alterations in the ALS–FTD Spectrum of Disorders
Juan M. Godoy-Corchuelo, Luis C. Fernández-Beltrán, Zeinab Ali, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1105-1105
Open Access | Times Cited: 23
Juan M. Godoy-Corchuelo, Luis C. Fernández-Beltrán, Zeinab Ali, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1105-1105
Open Access | Times Cited: 23
Integrated methylome and phenome study of the circulating proteome reveals markers pertinent to brain health
Danni A. Gadd, Robert F. Hillary, Daniel L. McCartney, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Danni A. Gadd, Robert F. Hillary, Daniel L. McCartney, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Tissue informative cell-free DNA methylation sites in amyotrophic lateral sclerosis
Christa Caggiano, Marco Morselli, Xia Qian, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Christa Caggiano, Marco Morselli, Xia Qian, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
The epigenetic modification of DNA methylation in neurological diseases
Linke Li, R Chen, Hui Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Linke Li, R Chen, Hui Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
A phenome-wide association study of methylated GC-rich repeats identifies a GCC repeat expansion in AFF3 associated with intellectual disability
Bharati Jadhav, Paras Garg, Joke J.F.A. van Vugt, et al.
Nature Genetics (2024)
Closed Access | Times Cited: 5
Bharati Jadhav, Paras Garg, Joke J.F.A. van Vugt, et al.
Nature Genetics (2024)
Closed Access | Times Cited: 5
Exposure to Metals, Pesticides, and Air Pollutants: Focus on Resulting DNA Methylation Changes in Neurodegenerative Diseases
Andrea Stoccoro, Fabio Coppedè
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1366-1366
Open Access | Times Cited: 5
Andrea Stoccoro, Fabio Coppedè
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1366-1366
Open Access | Times Cited: 5
The Role of Sphingomyelin and Ceramide in Motor Neuron Diseases
Gavin McCluskey, Colette Donaghy, Karen Morrison, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 9, pp. 1418-1418
Open Access | Times Cited: 21
Gavin McCluskey, Colette Donaghy, Karen Morrison, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 9, pp. 1418-1418
Open Access | Times Cited: 21
Effects of PB‐TURSO on the transcriptional and metabolic landscape of sporadic ALS fibroblasts
Jasmine A. Fels, Jalia Dash, Kent Leslie, et al.
Annals of Clinical and Translational Neurology (2022) Vol. 9, Iss. 10, pp. 1551-1564
Open Access | Times Cited: 21
Jasmine A. Fels, Jalia Dash, Kent Leslie, et al.
Annals of Clinical and Translational Neurology (2022) Vol. 9, Iss. 10, pp. 1551-1564
Open Access | Times Cited: 21
Aberrant DNA and RNA Methylation Occur in Spinal Cord and Skeletal Muscle of Human SOD1 Mouse Models of ALS and in Human ALS: Targeting DNA Methylation Is Therapeutic
Lee J. Martin, Danya A. Adams, Mark V. Niedzwiecki, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3448-3448
Open Access | Times Cited: 21
Lee J. Martin, Danya A. Adams, Mark V. Niedzwiecki, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3448-3448
Open Access | Times Cited: 21
Microglial crosstalk with astrocytes and immune cells in amyotrophic lateral sclerosis
Matteo Calafatti, Germana Cocozza, Cristina Limatola, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Matteo Calafatti, Germana Cocozza, Cristina Limatola, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
The Spectrum of Cognitive Dysfunction in Amyotrophic Lateral Sclerosis: An Update
K. A. Jellinger
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14647-14647
Open Access | Times Cited: 12
K. A. Jellinger
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14647-14647
Open Access | Times Cited: 12